NCM·Healthcare·$338M·#339 / 520 in Healthcare
ABEO Abeona Therapeutics Inc.
34HIGH RISK
CATEGORY BREAKDOWN
GROWTH0
QUALITY34
STABILITY57
VALUATION0
GOVERNANCE60
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
N/A
0
> 50% strong
Gross Margin
Revenue retained after direct costs
41.2%
57
> 50% strong
Cash Runway
Months of cash at current burn rate
12 months
41
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
15.7%
87
< 25% strong
Price / Sales
Market cap relative to trailing revenue
58.1x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
N/A
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
16.8%
79
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+16.2%
21
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ABEO WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when ABEO's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.